|
Market Closed -
Euronext Paris
11:55:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 1.402 EUR | +2.49% |
|
-8.01% | -12.48% |
| 09-20 | Innate Pharma S.A.(ENXTPA:IPH) added to S&P Global BMI Index | CI |
| 09-17 | Innate Pharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 131M 149M 124M 112M 212M 14.3B 215M 1.49B 573M 7.31B 560M 548M 23.44B | P/E 2026 * |
2.94x | P/E 2027 * | 0.65x |
|---|---|---|---|---|---|
| Enterprise Value | 33.27M 37.78M 31.52M 28.46M 53.63M 3.62B 54.33M 377M 145M 1.85B 142M 139M 5.94B | EV / Sales 2026 * |
0.75x | EV / Sales 2027 * | -1.54x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| IPH | Real-time | |
CBOE
| IPHp | Real-time | |
|
Börse Stuttgart
| IDD | Delayed | |
|
Xetra
| IDD | Delayed | |
|
Deutsche Boerse AG
| IDD | Delayed | |
|
London S.E.
| 0EVI | Delayed | |
|
CBOE
| 0EVI | Real-time | |
|
Tradegate
| IDD | Real-time | |
|
Boerse Muenchen
| IDD | Real-time | |
|
Borsa Italiana
| 4IPH | End-of-day quote |
Last Transcript: Innate Pharma
| 1 day | +2.49% | ||
| 1 week | -8.01% | ||
| 1 month | -23.97% | ||
| 3 months | -13.46% | ||
| 6 months | +32.77% | ||
| Current year | -12.48% |
| 1 week | 1.34 |  | 1.47 |
| 1 month | 1.34 | | 1.86 |
| Current year | 1.03 | | 2.33 |
| 1 year | 1.03 | | 2.33 |
| 3 years | 1.03 | | 2.8 |
| 5 years | 1.03 | | 5.58 |
| 10 years | 1.03 | | 15.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2024-10-31 | |
Frederic Lombard
DFI | Director of Finance/CFO | 51 | 2021-03-31 |
Markus Jensen
CTO | Chief Tech/Sci/R&D Officer | 57 | 2026-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 2023-12-31 | |
| Director/Board Member | 64 | 2015-04-26 | |
Pascale Boissel
BRD | Director/Board Member | 60 | 2020-05-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/14/26 | BPIFrance Participations SA /PRIVATE EQUITY/
| Buy | Company | 1,764,705 | 1.8789% | |
| 1/20/26 | Buy | Executive/Senior Manager | 50,000 | 0.0542% | ||
| 1/16/26 | Buy | Chief Financial Officer | 50,000 | 0.0542% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.49% | -8.01% | -17.92% | -45.13% | 145M | |
| +4.16% | -0.36% | +49.37% | +94.17% | 71.53B | |
| -0.19% | +1.32% | +37.20% | +83.85% | 60.12B | |
| -1.51% | +2.39% | +9.10% | +35.15% | 48.85B | |
| -0.05% | +0.37% | +41.54% | +36.65% | 44.28B | |
| +0.38% | +7.61% | +339.53% | +641.55% | 43.83B | |
| +0.18% | +0.26% | +7.41% | +103.45% | 41.53B | |
| -0.67% | +0.17% | +7.60% | +46.37% | 30.13B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 27.98B | |
| -1.29% | -3.55% | -20.74% | +352.04% | 25.25B | |
| Average | +0.83% | +0.26% | +48.99% | +137.09% | 39.36B | |
| Weighted average by Cap. | +0.80% | +1.37% | +60.90% | +148.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 44.17M 50.16M 41.85M 37.79M 71.22M 4.81B 72.14M 501M 193M 2.46B 188M 184M 7.88B | 107M 122M 102M 91.84M 173M 11.69B 175M 1.22B 468M 5.98B 458M 448M 19.16B |
| Net income | -8.91M -10.12M -8.44M -7.62M -14.37M -970M -14.55M -101M -38.88M -496M -38M -37.17M -1.59B | 25.08M 28.48M 23.76M 21.45M 40.43M 2.73B 40.95M 284M 109M 1.4B 107M 105M 4.48B |
| Net Debt | -98.1M -111M -92.95M -83.91M -158M -10.68B -160M -1.11B -428M -5.46B -418M -409M -17.51B | -297M -337M -282M -254M -479M -32.36B -485M -3.37B -1.3B -16.54B -1.27B -1.24B -53.04B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | €1.402 | +2.49% | 261,593 |
| 26-09-29 | €1.368 | -3.66% | 243,251 |
| 26-09-28 | €1.420 | -1.53% | 521,187 |
| 26-09-25 | €1.442 | -0.55% | 357,243 |
| 26-09-24 | €1.450 | -4.86% | 332,311 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPH Stock
Select your edition
All financial news and data tailored to specific country editions
